Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia

Japanese Circulation Journal

Volumn 62, Issue 3, 1998, Pages 167-172

  Matsuo, Shinro ^a   Nakamura, Yasuyuki ^a   Takahashi, Masayuki ^a   Mitsunami, Kenichi ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Exercise thallium 201; Hypertrophic cardiomyopathy; Iodine 123 BMIPP

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; RADIOPHARMACEUTICAL AGENT; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; EXERCISE TEST; FATTY ACID METABOLISM; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARDIOMYOPATHY, HYPERTROPHIC; ENERGY METABOLISM; EXERCISE TEST; FATTY ACIDS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 0031896517     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.167     Document Type: Article

References (40)

1. Cannon RO, Dilsizian V, O'Gara PT, Udelson JE, Schenke WH, Ouyyumi A, et al: Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991; 83: 1660-1667
2. Cannon RO, Dilsizian V, O'Gara PT, Udelson JE, Tucker E, Panza JA, et al: Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy. Circulation 1992; 85: 1039-1045
3. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L: Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 796-804
4. Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, et al: Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991; 17: 879-886
5. Maron BJ, Wolfson JK, Epstein SE, Roberts WC: Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-557
6. Bingisser R, Candinas R, Schneider J, Hess OM: Risk factors for systolic dysfunction and ventricular dilatation in hypertrophic cardiomyopathy. Int J Cardiol 1994; 44: 225-233
7. Yonekura Y, Brill AB, Som P, Yamamoto K, Srivastava SC, Iwai J, et al: Regional myocardial substrate uptake in hypertensive rats: a quantitative autoradiographic measurement. Science 1985; 27: 1178-1183
8. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al: Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667
9. NishimuraT, Sago M, Kihara K, Oka H, Shimonagata T, Katabuchi T, et al: Fatty acid myocardial imaging using 1231-beta-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1989; 15: 341-345
10. Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M: Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using iodine-123-labeled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (I-123-BMIPP). Nucl Med Commun 1994; 15: 441-447
11. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, et al: Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33: 6-13
12. Knapp FF, Franken P, Kropp J: Cardiac SPECT with iodine 123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995; 36: 1022-1030
13. Yamamichi Y, Kusuaka H, Morishita K, Shirakami Y, Kurami M, Okano K, et al: Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995; 36: 1043-1050
14. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al: Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodo-phenyl)-3-(R, S)methyl pentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822
15. Tamaki N, Tadamura E, Kawamoto M, Magata Y, Yonekura Y, Fujibayashi Y, et al: Decreased uptake of iodinated fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995; 36: 1974-1980
16. Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y, et al: Combined study with iodine-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8: 47-54
17. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathy. Br Heart J 1980; 44: 672-673
18. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, et al: Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979; 44: 401-412
19. Maron BJ, Gottdienner JS, Epstein SE: Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428
20. Nishimura T, Nagata S, Uehara T, Hayashida K, Mitani I, Kumita S: Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-111-antimyosin Fab myocardial scintigraphy. J Nucl Med 1991; 32: 1333-1337
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendation regarding quantitation in M-mode echocardiography: result of a survey of echocardiographic measurements. Circulation 1978; 44: 1072-1083
22. Devereux R, Reichek N: Echocardiographic determination of left ventricular mass in man. Circulation 1977; 13: 613-618
23. Navarro LF, Soler J, Magrina J, Esplugues E, Pare JC, Sanz G, et al: Systolic compression of coronary artery in hypertrophic cardiomyopathy. Int J Cardiol 1986; 12: 309-320
24. Matsuo S, Mitsunami K, Nakamura Y, Tsutamoto T, Yoshida S, Kusukawa J, et al: Evaluation of cardiac sympathetic nerve function in patients with hypertrophic cardiomyopathy using I-123 MIBG imaging. Ann Nucl Med 1996; 10: 256
25. Tadamura E, Tamaki N, Matsumori A, Magata Y, Yonekura Y, Nohara R, et al: Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med 1996; 37: 572-577
26. Matsunari I, Saga T, Taki J, Akashi Y, Hirai J, Wakasugi T, et al: Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994; 35: 1279-1285
27. Knapp FJ, Ambrose KR, Goodman MM: New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986; 12: S-39-S-44
28. Dudczak R, Schmoliner R, Angelberger P, Knapp FF, Goodman MM: Structurally modified fatty acids: clinical potential as tracers of metabolism. Eur J Nucl Med 1986; 12: S45-S48
29. Otto CA, Brown LE, Scott AM: Radioiodinated branched chain fatty acids: substrates for beta oxydation? J Nucl Med 1984; 24: 75-80
30. Miller DD, Gill JB, Elmaleh D, Arez T, Boucher CA, Strauss HW: Fatty acid analogue accumulation: a marker of myocite viability in ischemic-reperfused myocardium. Circ Res 1989; 63: 681-692
31. Yabe T, Mitsunami K, Inubushi T, Morikawa S, Yoshida S, Matsuo S: Evaluation of myocardial viability by P-31 magnetic resonance spectroscopy (MRS) during dynamic handgrip exercise. Circulation 1996; 94: 1-541
32. Suzuki A, Takada Y, Nagasaka M, Kato R, Watanabe T, Shimokata K, et al: Comparison of resting β-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina. Jpn Circ J 1997; 61: 133-138
33. 31P magnetic resonance spectroscopy during handgrip exercise. Circulation 1994; 89: 1709-1716
34. Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al: Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasoapastic angina. J Nucl Med 1995; 36: 1934-1940
35. 31P magnetic resonance spectroscopy. Lancet 1991; 338: 973-976
36. Hwang EH, Yamashita A, Takemori H, Taki J, Nakajima K, Bunko H, et al: Absent myocardial I-123 BMIPP uptake in a family. Ann Nucl Med 1996; 10: 445-448
37. Tanaka T, Sohmiya K, Kawamura K: Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997; 29: 121-127
38. Tanaka T, Okamoto F, Sohmiya K, Kawamura K: Lack of myocardial iodine-123 15-(p-iodiphenyl)-3-R, S-methylpentadecanoic acid (BMIPP) uptake and CD36 abnormality. Jpn Circ J 1997; 61: 724-725
39. Matsuo S.,Takahashi M, Nakamura Y, Kinoshita M: Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzyl-guanidine imaging in silent myocardial ischemia. J Nucl Med 1996; 37: 712-717
40. Matsuo S, Nakamura Y, Yamada T, Kawashima T, Kinoshita M: Warfarin reduces silent cerebral infarction in patients with atrial fibrillation. Can J Cardiol 1997; 13: 116B